Moran Kyle bought WVE
December 9, 2025 · Form 4 insider transaction
Moran Kyle bought 36,000 shares of Wave Life Sciences, Inc. at $8.17 per share, a transaction worth $294.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
36,000
Price
$8.17
Total value
$294.1K
InsiderMoran Kyle
RoleOfficer
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateDecember 9, 2025
Filing dateDecember 10, 2025
Shares owned after125,218
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.